Malignant Rectal Neoplasm — Trials

Malignant Rectal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,551 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 388
Recruiting: 216
Ph III recruiting: 36
Growth YoY: +12%
Industry share: 5%
Top sponsor: Fudan University
Termination share: 28%
Trials / 1,000 deaths: 30.1 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (153)

clinicaltrialsPublishedShowing 51–57 of 57 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06097416	Neoadjuvant Chemoradiotherapy Versus Total Neoadjuvant Therapy in the Treatment of T3 Rectal Cancer	not yet recruiting	Phase 3	100	St. James's Hospital, IrelandOTHER	0	Oct 25, 2023	clinicaltrials
NCT05984485	The Efficacy of Primary Total Mesorectal Excision (TME) Surgery Versus Neoadjuvant Chemotherapy Combined With TME Surgery in Low-risk Locally Advanced Rectal Cancer(TaLaR-02)	recruiting	Phase 3	766	Sun Yat-sen UniversityOTHER	1	Aug 9, 2023